Literature DB >> 4067207

Pseudotumor cerebri and thyroid-replacement therapy in patients affected by differentiated thyroid carcinoma.

N Panza, M De Rosa, G Lombardi, M Salvatore.   

Abstract

The pseudotumor cerebri, a neurological syndrome clinically characterized by headaches, vomiting and bilateral papilledema, occurred in two patients, previously subjected to total thyroidectomy for differentiated thyroid carcinoma, after initiation of levothyroxine replacement therapy. In patients with thyroid cancer, subjected to thyroidectomy and then thyroid hormone replacement therapy, the possible development of pseudotumor cerebri syndrome should be considered and differentiated from CNS symptoms due to brain metastases.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4067207     DOI: 10.1007/BF03348513

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  11 in total

1.  PSEUDOTUMOR CEREBRI ASSOCIATED WITH PROLONGED CORTICOSTEROID THERAPY. REPORTS OF FOUR CASES.

Authors:  A E WALKER; J J ADAMKIEWICZ
Journal:  JAMA       Date:  1964-06-01       Impact factor: 56.272

2.  Central neurological complications of hypoparathyroidism.

Authors:  O SUGAR
Journal:  AMA Arch Neurol Psychiatry       Date:  1953-07

3.  Serum thyroglobulin in patients with early thyroid cancer who have residual thyroid after total thyroidectomy.

Authors:  N Panza; M De Rosa; G Lombardi; M Salvatore
Journal:  Lancet       Date:  1984-02-18       Impact factor: 79.321

4.  Pseudotumor cerebri associated with initiation of levothyroxine therapy for juvenile hypothyroidism.

Authors:  C Van Dop; F A Conte; T K Koch; S J Clark; S L Wilson-Davis; M M Grumbach
Journal:  N Engl J Med       Date:  1983-05-05       Impact factor: 91.245

5.  Pseudotumor cerebri during treatment for hypothyroidism.

Authors:  J L Prendes; W T McLean
Journal:  South Med J       Date:  1978-08       Impact factor: 0.954

6.  131I total body scan and serum thyroglobulin assay in the follow-up of surgically treated patients affected by differentiated thyroid carcinoma.

Authors:  N Panza; G Lombardi; M Minozzi; M Salvatore; F Claudio; A Mariano; V Macchia
Journal:  J Nucl Med Allied Sci       Date:  1984 Jan-Mar

7.  Elevated serum thyroglobulin. A marker of metastases in differentiated thyroid carcinomas.

Authors:  A J Herle; R P Uller
Journal:  J Clin Invest       Date:  1975-08       Impact factor: 14.808

8.  Thyroglobulin assay in the follow-up of patients with differentiated thyroid carcinomas: comparison of its value in patients with or without normal residual tissue.

Authors:  M Schlumberger; P Fragu; C Parmentier; M Tubiana
Journal:  Acta Endocrinol (Copenh)       Date:  1981-10

9.  Serum thyroglobulin in thyroid carcinoma and other thyroid disorders.

Authors:  F Pacini; A Pinchera; C Giani; L Grasso; F Doveri; L Baschieri
Journal:  J Endocrinol Invest       Date:  1980 Jul-Sep       Impact factor: 4.256

10.  Benign intracranial hypertension following corticosteroid withdrawal in childhood.

Authors:  B G Neville; J Wilson
Journal:  Br Med J       Date:  1970-09-05
View more
  3 in total

1.  Idiopathic intracranial hypertension in a patient with thyroid papillary carcinoma.

Authors:  A Carotenuto; F Barbato; G Vacca; F Barbieri; G Orefice
Journal:  Neurol Sci       Date:  2013-07-14       Impact factor: 3.307

Review 2.  Adverse effects of thyroid hormones.

Authors:  J B Williams
Journal:  Drugs Aging       Date:  1997-12       Impact factor: 3.923

3.  Subacute Thyroiditis Presenting as Idiopathic Intracranial Hypertension.

Authors:  Kanyanatt Boonyatarp; Kanoksri Samintharapanya; Thanawat Vongchaiudomchoke; Nuttaya Wachiraphansakul
Journal:  Case Rep Endocrinol       Date:  2021-12-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.